GSK moves to Reduced Wholesaler distribution
GSK UK Pharmaceuticals is to change its current Direct to Pharmacy model to a Reduced Wholesaler model from 1 November 2018, withÂ PHOENIX UK being one of three companies selected to distribute GSKâ€™s prescription medicines to community pharmacies, hospitals and dispensing doctors throughout the UK.
Commenting on GSKâ€™s decision Steve Anderson, group managing director PHOENIX UK, said: â€œGSKâ€™s decision will be warmly welcomed by all our dispensing customers as it will provide them with greater convenience when ordering the GSK prescription medicines they need for their patients.â€
NumarkÂ managing director Jeremy Meader commented: â€œThis is an historic move by GSK that will ultimately be incredibly positive for community pharmacy.Â Times are tough and recognition of the challenges faced by pharmacy by increasing access to a wider range of prescription medicines through PHOENIX will help deliver consistency in service and increase patient loyalty whilst helping them to more effectively and efficiently fulfil their role on the front line of healthcare.â€
With research suggesting a possible link between COVID-19 and EPs, make sure you’re confident discussing EPs and their treatment with customers